Press release
ADHD Therapeutics Market Growth Insights, COVID-19 Impact Analysis, Size Projection, Future Trends and Share Estimation By 2025
ADHD Therapeutics Market
ADHD Therapeutics Market Overview:
As per the report published by Market Research Future (MRFR), the global ADHD therapeutics market is registered to grow steadily till the end of 2024. Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder with a group of behavioral symptoms that include hyperactivity, inattentiveness and impulsiveness. The symptoms of ADHD begin in childhood and can continue through adolescence and adulthood. Market Drivers and Restraints:
The symptoms of ADHD such as lack of attention, hyperactivity and impulsivity hamper proper functioning and development of an individual. Increasing awareness regarding neurodevelopmental disorders and easy availability of diagnostic guidelines over the internet is projected to boost the growth of the global ADHD therapeutics market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8570
Changing lifestyles and value systems along with the factors like genetic inheritance and premature birth are resulting to the rise in prevalence of ADHD among children in the age group of 4-17 years, which in turn is propelling the growth of the global ADHD therapeutics market. Increasing availability of online platforms for therapists that assure anonymity of the patient is inclining more individuals towards undergoing therapeutic treatment for ADHD, which in turn is fueling the expansion of the global ADHD therapeutics market
However, underdiagnosis of ADHD due to the existence of comorbid conditions in children, lack of awareness and low availability of non-stimulant drugs to treat ADHD in various regions are likely to hamper the expansion of the global ADHD therapeutics market during the forecast period.
ADHD Therapeutics Market Regional Analysis:
Geographically, the global ADHD therapeutics market is segmented into four major regions such as North America, Europe, Asia Pacific and the Middle East and Africa. The ADHD therapeutics market in the North America region accounts for the dominant share in the global ADHD therapeutics market owing to the increasing prevalence of ADHD in the children and high healthcare expenditure by the population in this region. The ADHD therapeutics market in the Europe region is projecting significant growth owing to the increased research and development for the introduction of more effective drugs in this region. The Asia Pacific region is anticipated to grow at a notable pace in the coming years due to
increased awareness regarding ADHD and its available treatments. Whereas, the Middle East and Africa region is projecting steady growth in the global ADHD market owing to the low awareness and poor primary health care in the underdeveloped areas of this region.
Industry Updates:
Ironshore Pharmaceuticals & Development, Inc., a subsidiary of Highland Therapeutics Inc., has received FDA approval for the New Drug Application for Jornay PM (methylphenidate) which was formerly known as HLD200 which is used for the treatment of ADHD in patients of the age six and older
Browse more details at: https://www.marketresearchfuture.com/reports/adhd-therapeutics-market-1573
FDA has issued a Complete Response Letter (CRL) to Sunovion Pharmaceutical asking for further clinical data to evaluate the efficacy of dasotraline, the ADHD drug.
ADHD Therapeutics Market Key Players:
The prominent players profiled by MRFR in the report on the global ADHD therapeutics market are Concordia International Corp., Eli Lilly and Company, Highland Therapeutics Inc., Janssen Global Services LLC, NEOS Therapeutics Inc., Novartis AG, Noven Pharmaceuticals Inc., Pfizer Inc., Shire, Teva Pharmaceutical and others.
Browse More Healthcare Research Reports at
Global Intravenous Immunoglobulin (IVIg) Market information, by type (IgA, IgD, IgE, IgG, IgM), by Appliaction (Chronic inflammatory demyelinating polyneuropathy (CIDP), Hypogammaglobulinemia, Multifocal Motor Neuropathy, Immunodeficiency diseases, Primary Humoral Immunodeficiency, Myasthenia Gravis, Guillain-Barre syndrome, Kawasaki disease, ITP, and others) - Forecast to 2023
https://www.marketresearchfuture.com/reports/intravenous-immunoglobulin-market-3137
UTI Treatment Market Trends, Share And Growth Analysis By Drug Class (Quinolones, Aminoglycosides, Β-Lactam, Azoles And Others), By Clinical Indications (Urethritis, Cystitis, Pyelonephritis), By End User (Hospitals And Self-Administered) - Forecast To 2023
https://www.marketresearchfuture.com/reports/uti-treatment-market-3146
Gastroparesis Treatment Market Information, by Gastroparesis Type (Idiopathic, Diabetic, Post-surgical and Others), by Drug Class (Prokinetic drugs, Antiemetics, Antidepressants and Others) and by Other Treatment (Jejunostomy, Gastric electric stimulation (GES) and Parenteral Nutrition) - Forecast till 2023
https://www.marketresearchfuture.com/reports/gastroparesis-treatment-market-3213
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ADHD Therapeutics Market Growth Insights, COVID-19 Impact Analysis, Size Projection, Future Trends and Share Estimation By 2025 here
News-ID: 2095045 • Views: …
More Releases for ADHD
My ADHD Life Journal by Meryl Bengtsson Offers a Fresh, Reflective Tool for ADHD …
Image: https://www.globalnewslines.com/uploads/2025/05/1748624322.jpg
In a world that often pushes individuals with ADHD to "try harder" or "focus more," author and ADHD life coach Meryl Bengtsson invites you to try something radically different. With her book and courses, she encourages you to listen to yourself. Her new book, My ADHD Life Journal: Building Self-Awareness [https://www.amazon.co.uk/My-ADHD-Life-Journal-Self-Awareness/dp/1967679673/], is a deeply personal and practical resource designed to guide individuals on a journey of gentle reflection and…
Rising Prevalence Of ADHD Spurs Growth In The Attention-Deficit Hyperactivity Di …
The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?
The market size for therapeutics related to attention deficit hyperactivity disorder (ADHD) has seen significant growth in…
ADHD Awareness Month: Dance Academy Founder Shares How Dance Helps Manage ADHD
This ADHD Awareness Month, Nix Academy - an up and coming dance and performing arts school - is highlighting the powerful impact of dance on managing ADHD symptoms. Founded by Nicky Rowe, who herself has ADHD, the academy has become a beacon of inclusivity, with around 40% of its students identifying as neurodiverse.
"Dance has been my lifeline in managing ADHD," says Nicky Rowe, Founder and Principal Teacher at Nix Academy.…
Global ADHD Drugs Market Research Report 2017
Qyresearchreports include new market research report "Global ADHD Drugs Market Research Report 2017" to its huge collection of research reports.
The research report offers a comprehensive analysis of the global ADHD Drugs market, emphasizing on the key factors impacting the growth of the market. The factors affecting the growth of the market have been studied thoroughly and valuation of the market has been provided in the report. This report provides accurate…
ADHD Answers from an ADHD Teen Brings Help to Parents, ADHD Boys
Sept. 4, 2006--Parents of boys with Attention Deficit Disorder (ADHD) have a new place to find answers to questions, problem-solving suggestions, and general help and support, both for their sons and for themselves. But the help comes from a source some will find surprising. \"Talk Back with Jack\" offers a forum for 11-year-old Jack Dixon to offer help and advice to ADHD boys and their parents as part of That\'s…
ADHD Myths — What If There Really Isn’t Anything Wrong with ADHD Children?
February 6, 2006 (Washington, D.C.) - An ADHD diagnosis can often signal a lifetime of struggles for children. But consider the case of Robbie Raffino.
Robbie used to rise every day like most eight-year-olds. He'd wipe the sleepiness from his eyes, throw on shorts and shirt that don't match and eat cereal while watching cartoons.
But the innocence ended there. He'd swallow his Ritalin, hop on the school bus and enter…
